Health
New anti-cancer drug breakthrough for prostate cancer – Griffith News
A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis (tumour spread) and drug resistance.
A new anti-cancer drug for prostate cancer overcomes the twin problems plaguing researchers for decades. It halts metastasis (tumour spread) and drug resistance.
Developed by Griffith University researcher Professor Des Richardson and colleagues from the University of Sydney, the drug known as DpC inhibits prostate specific antigen (PSA) as well as suppressing both androgen-dependent and independent arms of androgen receptor signalling.
The current gold standard for prostate cancer treatment i…
-
General11 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News22 hours agoCat-Sitting Leads to Chaos for Austin Butler in the Trailer for Darren Aronofsky’s New Crime-Thriller ‘Caught Stealing’
-
Noosa News21 hours agoIs Auckland New Zealand’s New Cultural Capital?
-
General21 hours agoThree maps that show the scale of the NSW flood disaster